CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory GlioblastomaJingshu Xiao, Deyin Guo|Cancer Research|2022Cited by 33